Page last updated: 2024-08-21

barium and Leukemia, Lymphocytic, Chronic, B-Cell

barium has been researched along with Leukemia, Lymphocytic, Chronic, B-Cell in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's4 (80.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, R; Jamieson, GP; Wiley, JS1
Chen, JR; Jamieson, GP; Snook, MB; Wiley, JS1
Cornish, JE; Gargett, CE; Wiley, JS1
Gargett, CE; Jamieson, GP; Snook, MB; Wiley, JS; Zhang, W1
Bendall, LJ; Buell, GN; Chessell, IP; Gu, BJ; Wiley, JS; Zhang, WY1

Other Studies

5 other study(ies) available for barium and Leukemia, Lymphocytic, Chronic, B-Cell

ArticleYear
The ATP4- receptor-operated channel (P2Z class) of human lymphocytes allows Ba2+ and ethidium+ uptake: inhibition of fluxes by suramin.
    Archives of biochemistry and biophysics, 1993, Aug-15, Volume: 305, Issue:1

    Topics: Adenosine Triphosphate; Barium; Biological Transport; Calcium; Ethidium; Flow Cytometry; Humans; Ion Channels; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Propidium; Protein Synthesis Inhibitors; Strontium; Suramin; Triazines; Verapamil

1993
The P2Z-purinoceptor of human lymphocytes: actions of nucleotide agonists and irreversible inhibition by oxidized ATP.
    British journal of pharmacology, 1994, Volume: 112, Issue:3

    Topics: Adenosine Triphosphate; Barium; Calcium; Culture Media; Cytosol; Fluorometry; Humans; In Vitro Techniques; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocytes; Oxidation-Reduction; Potassium; Purine Nucleotides; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Sodium; Tumor Cells, Cultured

1994
ATP, a partial agonist for the P2Z receptor of human lymphocytes.
    British journal of pharmacology, 1997, Volume: 122, Issue:5

    Topics: 1-(5-Isoquinolinesulfonyl)-2-Methylpiperazine; Adenosine Triphosphate; Affinity Labels; Barium; Dose-Response Relationship, Drug; Enzyme Inhibitors; Ethidium; Flow Cytometry; Humans; In Vitro Techniques; Ion Channels; Leukemia, Lymphocytic, Chronic, B-Cell; Linear Models; Lymphocytes; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Structure-Activity Relationship; Thionucleotides

1997
Partial agonists and antagonists reveal a second permeability state of human lymphocyte P2Z/P2X7 channel.
    The American journal of physiology, 1998, Volume: 275, Issue:5

    Topics: Adenosine Triphosphate; B-Lymphocytes; Barium; Calcium; Cell Membrane Permeability; Cells, Cultured; Cloning, Molecular; Humans; Kinetics; Leukemia, Lymphocytic, Chronic, B-Cell; Liver; Macrophages; Monocytes; Purinergic P2 Receptor Agonists; Purinergic P2 Receptor Antagonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reverse Transcriptase Polymerase Chain Reaction; Thionucleotides

1998
Expression of P2X(7) purinoceptors on human lymphocytes and monocytes: evidence for nonfunctional P2X(7) receptors.
    American journal of physiology. Cell physiology, 2000, Volume: 279, Issue:4

    Topics: Adenosine Triphosphate; Antibodies, Monoclonal; Barium; Blood Platelets; Ethidium; Flow Cytometry; Humans; Intracellular Fluid; L-Selectin; Leukemia, Lymphocytic, Chronic, B-Cell; Lymphocyte Subsets; Lymphocytes; Monocytes; Polymerase Chain Reaction; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Receptors, Purinergic P2X7; Reference Values; RNA, Messenger

2000